Post Approval Studies 2013 is a conference that covers topics such as:
- How organisations are conducting their post-approval safety studies
- What Health Technology Assessors and Regulators will be looking for in the future
Post Approval Studies 2013 brings together attendees from Pharma and Biotech companies, including:
- Medical Directors
- Medical Affairs
- Epidemiology
- Late Phase Leaders
- Observational Research
- Late Phase Clinical Trials
- Market Access
- Outcomes
- Health Economics
- Product Alliance Support
- Brand Safety